Wew insight into the cause of psoriasis, more effective treatments, and identification of novel drug targets could provide new hope for the treatment of one of the most prevalent autoimmune diseases.
June is Scleroderma Awareness Month, which marks an appropriate time to review and highlight this rare autoimmune disease.
An overview of product candidates in clinical trials and the more than 30 life science companies developing novel therapies for Alzheimer’s disease
With spring around the corner, it seemed an appropriate time to examine Wall Street’s latest tulip obsession, which relates to the potential of targeting cancer stem cells…
Eight companies with immunotherapy approaches for brain tumors